Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnosis of chylous abdominal effusions: what is the triglyceride threshold value?
Lefrère B, Curis E, Bittar R, Levasseur A, Grès P, Guilbert Z, Zenati B, Cherfils C, Sakka M, Bonnefont-Rousselot D. Lefrère B, et al. Among authors: sakka m. Biochem Med (Zagreb). 2023 Jun 15;33(2):020902. doi: 10.11613/BM.2023.020902. Epub 2023 Apr 15. Biochem Med (Zagreb). 2023. PMID: 37143714 Free PMC article.
[Chylopericardium or contamination by injectable lipid emulsion?].
Lefrère B, Bittar R, Levasseur A, Lambe C, Abi-Nader E, Pontailler M, Gaudin R, Fesel-Fouquier V, Sakka M, Bonnefont-Rousselot D. Lefrère B, et al. Among authors: sakka m. Ann Biol Clin (Paris). 2022 Sep 1;80(5):478-486. doi: 10.1684/abc.2022.1753. Ann Biol Clin (Paris). 2022. PMID: 36453738 French.
Could the chylomicron marker apoB48 be of value in the diagnosis of chylous effusions?
Lefrère B, Sakka M, Fourati S, Levasseur A, Curis E, Cherfils C, Grès P, Guilbert Z, Lacorte JM, Chenevière C, Bittar R, Bonnefont-Rousselot D. Lefrère B, et al. Among authors: sakka m. Clin Chim Acta. 2023 Jan 15;539:184-190. doi: 10.1016/j.cca.2022.11.022. Epub 2022 Dec 1. Clin Chim Acta. 2023. PMID: 36463939
Postoperative Drainage Fluid with a Syrupy Appearance.
Lefrère B, Sakka M, Bittar R, Gaujoux S, Bonnefont-Rousselot D. Lefrère B, et al. Among authors: sakka m. Clin Chem. 2023 Mar 1;69(3):309-310. doi: 10.1093/clinchem/hvac201. Clin Chem. 2023. PMID: 36857216 No abstract available.
Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors.
Parlati L, Sakka M, Retbi A, Bouam S, Hassani L, Meritet JF, Rufat P, Bonnefont-Rousselot D, Batista R, Terris B, Bellanger A, Thabut D, Vozy A, Spano JP, Coriat R, Goldwasser F, Aractingi S, Sogni P, Pol S, Mallet V; CERTIM Research Group; DEMOSTHENES Research Group. Parlati L, et al. Among authors: sakka m. JHEP Rep. 2023 Aug 12;5(12):100880. doi: 10.1016/j.jhepr.2023.100880. eCollection 2023 Dec. JHEP Rep. 2023. PMID: 38074948 Free PMC article.
Other causes of neurocognitive impairment than covert hepatic encephalopathy (CHE) are very frequent, either alone or associated with CHE, in cirrhotic patients with cognitive complaints.
Sultanik P, Kheloufi L, Leproux A, Bouzbib C, Mouri S, Santiago A, Galanaud D, Navarro V, Sakka M, Rudler M, Weiss N, Thabut D. Sultanik P, et al. Among authors: sakka m. Aliment Pharmacol Ther. 2024 Sep;60(6):749-764. doi: 10.1111/apt.18148. Epub 2024 Jul 7. Aliment Pharmacol Ther. 2024. PMID: 38973133
246 results